1
|
Moazen B, Ismail N, Agbaria N, Mazzilli S, Petri D, Amaya A, D’Arcy J, Plugge E, Tavoschi L, Stöver H. Vaccination against emerging and reemerging infectious diseases in places of detention: a global multistage scoping review. Front Public Health 2024; 12:1323195. [PMID: 38347924 PMCID: PMC10859397 DOI: 10.3389/fpubh.2024.1323195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2023] [Accepted: 01/04/2024] [Indexed: 02/15/2024] Open
Abstract
Background Despite the elevated risks of infection transmission, people in prisons frequently encounter significant barriers in accessing essential healthcare services in many countries. The present scoping review aimed to evaluate the state of availability and model of delivery of vaccination services within correctional facilities across the globe. Methods Following the methodological framework for scoping reviews and adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for scoping reviews criteria, we conducted a systematic search across four peer-reviewed literature databases (Medline via PubMed, Web of Science, the Cochrane Library, Science Direct, and EBSCO), as well as 14 sources of grey literature. Two researchers meticulously examined the identified papers independently to extract pertinent data published between 2012 and 2022. The quality of the selected publications was assessed using established quality assessment tools. Results Of the 11,281 identified papers 52 met the inclusion criteria. With the exception of one, all the included publications presented data from high-income countries, predominantly originating from the United States. Across the world, the most prevalent vaccines available in prison settings were COVID-19 and HBV vaccines, typically distributed in response to health crises such as pandemics, epidemics, and local outbreaks. Vaccine coverage and uptake rates within correctional facilities displayed noteworthy disparities among various countries and regions. Besides, individual and organizational barriers and facilitating factors of vaccination in prison settings emerged and discussed in the text. Discussion The lack of vaccination services combined with low rates of vaccination coverage and uptake among people living and working in correctional facilities represents a cause for concern. Prisons are not isolated from the broader community, therefore, efforts to increase vaccine uptake among people who live and work in prisons will yield broader public health benefits.
Collapse
Affiliation(s)
- Babak Moazen
- Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany
- Department of Health and Social Work, Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, Frankfurt, Germany
| | - Nasrul Ismail
- School for Policy Studies, University of Bristol, Bristol, United Kingdom
| | - Nisreen Agbaria
- Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany
- Department of Health and Social Work, Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, Frankfurt, Germany
| | - Sara Mazzilli
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
| | - Davide Petri
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
| | - Arianna Amaya
- Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany
| | | | - Emma Plugge
- UK Health Security Agency, London, United Kingdom
- Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
| | - Lara Tavoschi
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
| | - Heino Stöver
- Department of Health and Social Work, Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, Frankfurt, Germany
| |
Collapse
|
2
|
Ramaswamy M, Manz C, Kouyoumdjian F, Vest N, Puglisi L, Wang E, Salyer C, Osei B, Zaller N, Rebbeck TR. Cancer equity for those impacted by mass incarceration. J Natl Cancer Inst 2023; 115:1128-1131. [PMID: 37219371 PMCID: PMC10560595 DOI: 10.1093/jnci/djad087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2023] [Revised: 04/26/2023] [Accepted: 05/11/2023] [Indexed: 05/24/2023] Open
Abstract
The cancer disparities between people with incarceration histories compared with those who do not have those histories are vast. Opportunities for bolstering cancer equity among those impacted by mass incarceration exist in criminal legal system policy; carceral, community, and public health linkages; better cancer prevention, screening, and treatment services in carceral settings; expansion of health insurance; education of professionals; and use of carceral sites for health promotion and transition to community care. Clinicians, researchers, persons with a history of incarceration, carceral administrators, policy makers, and community advocates could play a cancer equity role in each of these areas. Raising awareness and setting a cancer equity plan of action are critical to reducing cancer disparities among those affected by mass incarceration.
Collapse
Affiliation(s)
- Megha Ramaswamy
- Population Health, Obstetrics and Gynecology, University of Kansas Medical Center/University of Kansas Cancer Center, Kansas City, KS, USA
| | - Christopher Manz
- Medical Oncology, Population Sciences, Dana-Farber/Harvard Cancer Center, Boston, MA, USA
| | | | - Noel Vest
- Community Health Sciences, School of Public Health, Boston University, Boston, MA, USA
| | - Lisa Puglisi
- Medicine, Yale School of Medicine, New Haven, CT, USA
| | - Emily Wang
- Medicine, Yale School of Medicine, New Haven, CT, USA
| | - Chelsea Salyer
- Population Health, Obstetrics and Gynecology, University of Kansas Medical Center/University of Kansas Cancer Center, Kansas City, KS, USA
| | - Beverly Osei
- Family Medicine, McMaster University, Hamilton, ON, Canada
| | - Nick Zaller
- Health Behavior and Health Education, College of Public Health, University of Arkansas Medical Sciences, Little Rock, AR, USA
| | - Timothy R Rebbeck
- Medical Oncology, Population Sciences, Dana-Farber/Harvard Cancer Center, Boston, MA, USA
| |
Collapse
|
3
|
Moazen B, Agbaria N, Ismail N, Mazzilli S, Klankwarth UB, Amaya A, Rosello A, D'Arcy J, Plugge E, Stöver H, Tavoschi L. Interventions to increase vaccine uptake among people who live and work in prisons: A global multistage scoping review. JOURNAL OF COMMUNITY PSYCHOLOGY 2023. [PMID: 37462954 DOI: 10.1002/jcop.23077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/05/2023] [Accepted: 07/08/2023] [Indexed: 08/03/2023]
Abstract
The objective of this study is to examine interventions implemented to increase vaccine uptake among people who live and work in prisons around the world. Peer-reviewed and gray literature databases were searched systematically to identify relevant information published from 2012 to 2022. Publications were evaluated by two researchers independently and underwent quality assessment through established tools. Of the 11,281 publications identified through peer-reviewed (2607) and gray literature (8674) search, 17 met the inclusion criteria. In light of limited data, the identified interventions were categorized into two categories of educational and organizational interventions, and are discussed in the text. The lack of availability of vaccination services and interventions to increase vaccine uptake among people who live and work in prisons, worldwide, is a serious public health concern. These interventions reported in this review can be adapted and adopted to mitigate the burden of infectious diseases among people who live and work in prisons.
Collapse
Affiliation(s)
- Babak Moazen
- Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany
- Department of Health and Social Work, Frankfurt University of Applied Sciences, Frankfurt/Main, Germany
| | - Nisreen Agbaria
- Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany
- Department of Health and Social Work, Frankfurt University of Applied Sciences, Frankfurt/Main, Germany
| | - Nasrul Ismail
- School for Policy Studies, University of Bristol, Bristol, UK
| | - Sara Mazzilli
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
| | - Ulla-Britt Klankwarth
- Department of Health and Social Work, Frankfurt University of Applied Sciences, Frankfurt/Main, Germany
| | - Arianna Amaya
- Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany
| | | | | | - Emma Plugge
- UK Health Security Agency, London, UK
- Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, UK
| | - Heino Stöver
- Department of Health and Social Work, Frankfurt University of Applied Sciences, Frankfurt/Main, Germany
| | - Lara Tavoschi
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
| |
Collapse
|
4
|
Lipnicky A, Stites S, Sufrin C, Bello JK, Shlafer R, Kelly PJ, Ramaswamy M. Jail Provision of Pregnancy and Sexual Health Services in Four Midwestern States. Womens Health Issues 2023; 33:97-104. [PMID: 36096980 DOI: 10.1016/j.whi.2022.07.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2021] [Revised: 07/10/2022] [Accepted: 07/21/2022] [Indexed: 02/01/2023]
Abstract
OBJECTIVE Women incarcerated in local jails have pregnancy and sexual health needs, yet little information is available about what services are provided and how jail administrators prioritize this care. Our objective was to document jails' provision of pregnancy and sexual health services in four states in the Midwest. METHODS We invited all jail administrators (N = 347) in Kansas, Missouri, Iowa, and Nebraska to participate in a web-based survey conducted from November 2017 to October 2018. We asked administrators which pregnancy and sexual health services they offered and to rate the importance of offering services. Results were analyzed using descriptive statistics and logistic regression. RESULTS The survey response rate was 55% (192/347). Jails most often provided pregnancy testing (n = 116 [60%]) and distribution of prenatal vitamins (n = 85 [44%]). Sexually transmitted infection treatment was offered at 23% of jails (n = 45). Larger, accredited jails located in urban areas and with high numbers of clinical providers on staff were more likely to provide sexual health services. Jails with privately contracted health care were more likely to provide pregnancy services compared with other entities providing medical care. The most prioritized sexual health service was sexually transmitted infection testing, with 39% of administrators believing it was important. Only 6% of administrators responded that contraception was important. CONCLUSIONS Local jails in the Midwest do not meet the basic reproductive and sexual health needs of women. Provision of these services is not a priority for jail administrators. Appropriate partnerships could engage administrators and increase the availability of services to meet the needs of women in jail.
Collapse
Affiliation(s)
- Ashlyn Lipnicky
- University of Kansas School of Medicine, Kansas City, Kansas
| | - Sierra Stites
- University of Kansas School of Medicine, Kansas City, Kansas
| | | | | | - Rebecca Shlafer
- University of Minnesota Medical School, Minneapolis, Minnesota
| | | | - Megha Ramaswamy
- University of Kansas School of Medicine, Kansas City, Kansas
| |
Collapse
|
5
|
Di Giuseppe G, Folcarelli L, Lanzano R, Napolitano F, Pavia M. HPV Vaccination and Cervical Cancer Screening: Assessing Awareness, Attitudes, and Adherence in Detained Women. Vaccines (Basel) 2022; 10:vaccines10081280. [PMID: 36016168 PMCID: PMC9416201 DOI: 10.3390/vaccines10081280] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2022] [Revised: 08/03/2022] [Accepted: 08/05/2022] [Indexed: 12/04/2022] Open
Abstract
Background: This study assessed awareness, attitudes, and uptake of human papillomavirus (HPV) vaccination and cervical cancer screening in detained women. Methods: The cross-sectional study was conducted from April to June 2022 in four women prisons in Italy. Results: 41.1% of participants recognized HPV infection as an sexually transmitted diseases (STD), 36.4% identified cervical, and 16.8% oral cancer as an HPV-associated disease. Overall, 70% had never heard of HPV vaccination, and 45.8% believed it is effective to prevent cervical cancer. Among the age-eligible women for HPV vaccination, none reported to have undergone it, nor had talked about it with a physician in the previous year. Only 13.5% declared to have ever undergone cervical cancer screening, and adherence was significantly higher in those who were involved in a working activity in prison, who were aware that HPV infection is an STD and that can cause cervical and oral cancer, and who were older at their first sexual intercourse. Conclusion: These findings documented an extremely low awareness of HPV infection and an unsatisfactory adherence to prevention through HPV vaccination and cervical cancer screening. There is a need for evidence-based interventions for incarcerated women to promote participation in HPV vaccination and cervical cancer screening programs as routine activities.
Collapse
|
6
|
Spaulding AC, Rabeeah Z, Del Mar González-Montalvo M, Akiyama MJ, Baker BJ, Bauer HM, Gibson BR, Nijhawan AE, Parvez F, Wangu Z, Chan PA. Prevalence and Management of Sexually Transmitted Infections in Correctional Settings: A Systematic Review. Clin Infect Dis 2022; 74:S193-S217. [PMID: 35416974 PMCID: PMC9989347 DOI: 10.1093/cid/ciac122] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
Admissions to jails and prisons in the United States number 10 million yearly; persons entering locked correctional facilities have high prevalence of sexually transmitted infections (STIs). These individuals come disproportionately from communities of color, with lower access to care and prevention, compared with the United States as a whole. Following PRISMA guidelines, the authors present results of a systematic review of literature published since 2012 on STIs in US jails, prisons, Immigration and Customs Enforcement detention centers, and juvenile facilities. This updates an earlier review of STIs in short-term facilities. This current review contributed to new recommendations in the Centers for Disease Control and Prevention 2021 treatment guidelines for STIs, advising screening for Trichomonas in women entering correctional facilities. The current review also synthesizes recommendations on screening: in particular, opt-out testing is superior to opt-in protocols. Carceral interventions-managing diagnosed cases and preventing new infections from occurring (eg, by initiating human immunodeficiency virus preexposure prophylaxis before release)-can counteract structural racism in healthcare.
Collapse
Affiliation(s)
- Anne C Spaulding
- Departments of Epidemiology and Global Health, Rollins School of Public Health; Emory University, Atlanta, Georgia, USA.,Department of Medicine, Division of Infectious Disease, Emory School of Medicine, Emory University, Atlanta, Georgia, USA
| | - Zainab Rabeeah
- Departments of Epidemiology and Global Health, Rollins School of Public Health; Emory University, Atlanta, Georgia, USA
| | | | - Matthew J Akiyama
- Department of Medicine, Divisions of General Internal Medicine and Infectious Diseases, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA
| | - Brenda J Baker
- Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia, USA
| | - Heidi M Bauer
- California Correctional Health Care Services, Elk Grove, California, USA.,Department of Epidemiology, School of Public Health, University of California, Berkeley, Berkeley, California, USA
| | - Brent R Gibson
- National Commission on Correctional Healthcare, Chicago, Illinois, USA
| | - Ank E Nijhawan
- Department of Medicine, Division of Infectious Disease and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA
| | - Farah Parvez
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Tuberculosis Elimination, Field Services Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.,Bureau of Tuberculosis Control, Division of Disease Control, New York City Department of Health and Mental Hygiene, New York City, New York, USA
| | - Zoon Wangu
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Tuberculosis Elimination, Field Services Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.,Bureau of Tuberculosis Control, Division of Disease Control, New York City Department of Health and Mental Hygiene, New York City, New York, USA.,Department of Pediatrics, Division of Pediatric Infectious Diseases & Immunology, UMass Memorial Children's Medical Center & UMass Chan Medical School, Worcester, Massachusetts, USA.,Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA
| | - Philip A Chan
- Department of Medicine, Division of Infectious Disease, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.,Department of Behavioral and Social Sciences at the Brown University School of Public Health, Providence, Rhode Island, USA.,National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of STD Elimination, National Centers for Disease Control and Elimination, Atlanta, Georgia, USA
| | | |
Collapse
|
7
|
Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021; 70:1-187. [PMID: 34292926 PMCID: PMC8344968 DOI: 10.15585/mmwr.rr7004a1] [Citation(s) in RCA: 713] [Impact Index Per Article: 237.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
These guidelines for the treatment of persons who have or are at risk for
sexually transmitted infections (STIs) were updated by CDC after consultation
with professionals knowledgeable in the field of STIs who met in Atlanta,
Georgia, June 11–14, 2019. The information in this report updates the
2015 guidelines. These guidelines discuss 1) updated recommendations for
treatment of Neisseria gonorrhoeae, Chlamydia trachomatis,
and Trichomonas vaginalis; 2) addition of
metronidazole to the recommended treatment regimen for pelvic inflammatory
disease; 3) alternative treatment options for bacterial vaginosis; 4) management
of Mycoplasma genitalium; 5) human papillomavirus vaccine
recommendations and counseling messages; 6) expanded risk factors for syphilis
testing among pregnant women; 7) one-time testing for hepatitis C infection; 8)
evaluation of men who have sex with men after sexual assault; and 9) two-step
testing for serologic diagnosis of genital herpes simplex virus. Physicians and
other health care providers can use these guidelines to assist in prevention and
treatment of STIs.
Collapse
|
8
|
Ramaswamy M, Satterwhite CL, Lipnicky A, Emerson A, Griffin P, Ash D, Ault K. Recommendations for Delivering COVID-19 Vaccine in Jails: Evidence from Kansas, Iowa, Nebraska, and Missouri. Am J Public Health 2021; 111:1035-1039. [PMID: 33950714 DOI: 10.2105/ajph.2021.306218] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
We report on data we collected from a 2018 survey examining jails' human papillomavirus virus vaccine delivery capacity and on a secondary analysis we conducted to describe factors similarly associated with delivery planning for the COVID-19 vaccine. We provide recommendations for delivering the COVID-19 vaccine in jails, based on evidence from Kansas, Iowa, Nebraska, and Missouri. Our key finding is that jails have limited staff to implement vaccination and will require collaboration between jail administrators, jail medical staff, and local health departments.
Collapse
Affiliation(s)
- Megha Ramaswamy
- Megha Ramaswamy, Ashlyn Lipnicky, and Kevin Ault are with the University of Kansas Medical Center, Kansas City. Catherine L. Satterwhite is with the Office of the Assistant Secretary for Health, US Department of Health and Human Services, Kansas City, MO. Amanda Emerson is with the School of Nursing and Health Studies, University of Missouri-Kansas City. Phil Griffin is with the Bureau of Disease Control and Prevention, Kansas Department of Health and Environment, Topeka. Donald Ash is with the Wyandotte County, Kansas Sheriff's Office, Kansas City, KS
| | - Catherine L Satterwhite
- Megha Ramaswamy, Ashlyn Lipnicky, and Kevin Ault are with the University of Kansas Medical Center, Kansas City. Catherine L. Satterwhite is with the Office of the Assistant Secretary for Health, US Department of Health and Human Services, Kansas City, MO. Amanda Emerson is with the School of Nursing and Health Studies, University of Missouri-Kansas City. Phil Griffin is with the Bureau of Disease Control and Prevention, Kansas Department of Health and Environment, Topeka. Donald Ash is with the Wyandotte County, Kansas Sheriff's Office, Kansas City, KS
| | - Ashlyn Lipnicky
- Megha Ramaswamy, Ashlyn Lipnicky, and Kevin Ault are with the University of Kansas Medical Center, Kansas City. Catherine L. Satterwhite is with the Office of the Assistant Secretary for Health, US Department of Health and Human Services, Kansas City, MO. Amanda Emerson is with the School of Nursing and Health Studies, University of Missouri-Kansas City. Phil Griffin is with the Bureau of Disease Control and Prevention, Kansas Department of Health and Environment, Topeka. Donald Ash is with the Wyandotte County, Kansas Sheriff's Office, Kansas City, KS
| | - Amanda Emerson
- Megha Ramaswamy, Ashlyn Lipnicky, and Kevin Ault are with the University of Kansas Medical Center, Kansas City. Catherine L. Satterwhite is with the Office of the Assistant Secretary for Health, US Department of Health and Human Services, Kansas City, MO. Amanda Emerson is with the School of Nursing and Health Studies, University of Missouri-Kansas City. Phil Griffin is with the Bureau of Disease Control and Prevention, Kansas Department of Health and Environment, Topeka. Donald Ash is with the Wyandotte County, Kansas Sheriff's Office, Kansas City, KS
| | - Phil Griffin
- Megha Ramaswamy, Ashlyn Lipnicky, and Kevin Ault are with the University of Kansas Medical Center, Kansas City. Catherine L. Satterwhite is with the Office of the Assistant Secretary for Health, US Department of Health and Human Services, Kansas City, MO. Amanda Emerson is with the School of Nursing and Health Studies, University of Missouri-Kansas City. Phil Griffin is with the Bureau of Disease Control and Prevention, Kansas Department of Health and Environment, Topeka. Donald Ash is with the Wyandotte County, Kansas Sheriff's Office, Kansas City, KS
| | - Donald Ash
- Megha Ramaswamy, Ashlyn Lipnicky, and Kevin Ault are with the University of Kansas Medical Center, Kansas City. Catherine L. Satterwhite is with the Office of the Assistant Secretary for Health, US Department of Health and Human Services, Kansas City, MO. Amanda Emerson is with the School of Nursing and Health Studies, University of Missouri-Kansas City. Phil Griffin is with the Bureau of Disease Control and Prevention, Kansas Department of Health and Environment, Topeka. Donald Ash is with the Wyandotte County, Kansas Sheriff's Office, Kansas City, KS
| | - Kevin Ault
- Megha Ramaswamy, Ashlyn Lipnicky, and Kevin Ault are with the University of Kansas Medical Center, Kansas City. Catherine L. Satterwhite is with the Office of the Assistant Secretary for Health, US Department of Health and Human Services, Kansas City, MO. Amanda Emerson is with the School of Nursing and Health Studies, University of Missouri-Kansas City. Phil Griffin is with the Bureau of Disease Control and Prevention, Kansas Department of Health and Environment, Topeka. Donald Ash is with the Wyandotte County, Kansas Sheriff's Office, Kansas City, KS
| |
Collapse
|
9
|
Emerson A, Allison M, Saldana L, Kelly PJ, Ramaswamy M. Collaborating to offer HPV vaccinations in jails: results from a pre-implementation study in four states. BMC Health Serv Res 2021; 21:309. [PMID: 33827560 PMCID: PMC8028758 DOI: 10.1186/s12913-021-06315-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2020] [Accepted: 03/24/2021] [Indexed: 12/22/2022] Open
Abstract
BACKGROUND Correctional facilities are an underutilized venue for reaching young adults who have not vaccinated for human papillomavirus (HPV). The objective of this study was to identify factors that are associated with jail and local health department (LHD) interest in partnering to offer HPV vaccinations to young adults in jail. METHODS Consolidated framework for implementation research (CFIR)-guided surveys were conducted with jail administrators in Iowa, Kansas, Missouri, and Nebraska, September 2017-October 2018. Jail survey data were analyzed using chi square distribution and relative risk regression. Using data from sister surveys conducted with LHD administrators in the same counties (results previously reported), we identified characteristics of counties in which both the jail and LHD indicated interest in collaborating to offer HPV vaccinations in the jail. RESULTS Jail survey response was 192/347 (55.3%). Surveys with LHDs yielded 237/344 (68.9%) responses. Eleven communities were identified where both the jail and LHD expressed interest. Only "any vaccines provided in jail" predicted shared interest (RR: 5.36; CI: 2.52-11.40; p < .01). For jail administrators, offering other vaccines was 3 times (CI:1.49-6.01; p < .01) and employing a nurse 1.65 times more likely (CI: 1.20-2.28; p < .01) to predict interest in collaborating to offer HPV vaccination. Open-ended responses indicated that managing linkages and stakeholder investment were areas of emphasis where collaborations to provide vaccinations in the jails had been previously implemented. CONCLUSIONS Interest in jail-LHD partnerships to provide HPV vaccinations in jails exists in the Midwest but will require building-out existing programs and linkages and identifying and strengthening shared values, goals, and benefits at all levels.
Collapse
Affiliation(s)
- Amanda Emerson
- School of Nursing and Health Studies, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO, 64108, USA.
| | - Molly Allison
- College of Veterinary Medicine, Kansas State University, Manhattan, KS, 66506, USA
| | - Lisa Saldana
- Oregon Social Learning Center, 10 Shelton McMurphey Blvd., Eugene, Oregon, 97401, USA
| | - Patricia J Kelly
- Jefferson School of Nursing, Thomas Jefferson University, Center City Campus, 901 Walnut Street, 8th Floor, Philadelphia, PA, 19107, USA
| | - Megha Ramaswamy
- Department of Population Health, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA
| |
Collapse
|
10
|
Local Health Department Interest in Implementation of a Jail-Based Human Papillomavirus Vaccination Program in Kansas, Iowa, Missouri, and Nebraska. JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE 2020; 26:168-175. [PMID: 31313718 DOI: 10.1097/phh.0000000000001021] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
CONTEXT Local health departments (LHDs) play a vital role in community vaccination programs for human papillomavirus (HPV) infection, but little research has been done to assess LHD interest in cross-sectoral partnerships to vaccinate high-risk groups, specifically incarcerated persons. OBJECTIVE To describe factors associated with interest in a novel implementation strategy linking LHDs with jails in 4 Midwestern states to deliver HPV vaccine. DESIGN Survey based on the Consolidated Framework for Implementation Research (CFIR) model given to LHD administrators. A modified Poisson relative risk regression was used to assess the relationship between independent variables and LHD interest in implementation of a jail-based HPV vaccination program. SETTING LHDs in Kansas, Missouri, Iowa, and Nebraska. PARTICIPANTS From September 2017 to April 2018, two-thirds (237/344) of invited LHD administrators from the 4 states responded to the survey. MAIN OUTCOME MEASURE LHD interest in implementation of a jail-based HPV vaccination program. RESULTS Forty-five percent of LHDs were interested in learning more about implementing a jail-based HPV vaccination program, and 2% already offered or had plans to offer HPV vaccine in their jails. Barriers to implementation were cost (66%), inmates' short incarcerations (47%), and availability of medical staffing (43%). LHD characteristics associated with interest in implementation of a jail-based HPV vaccination program included "inner setting" CFIR variables, which capture the structural and cultural context for program implementation: 7 or more employees (odds ratio [OR] = 2.22; 95% confidence interval [CI], 1.24-3.95), perception of importance to provide HPV vaccine in jails (OR = 3.70; 95% CI, 2.00-6.84), and already providing any vaccines in jails (OR = 2.62; 95% CI, 1.18-5.80). CONCLUSIONS Nearly half of LHDs in the region expressed interest in partnering with local entities to meet HPV vaccination needs of high-risk groups. Research on cross-sectoral partnerships and what these collaborations look like in practice is needed for public health impact.
Collapse
|
11
|
Özdemir S, Akkaya R, Karaşahin KE. Analysis of community-based studies related with knowledge, awareness, attitude, and behaviors towards HPV and HPV vaccine published in Turkey:
A systematic review. J Turk Ger Gynecol Assoc 2020; 21:111-123. [PMID: 31397145 PMCID: PMC7294837 DOI: 10.4274/jtgga.galenos.2019.2019.0071] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2019] [Accepted: 07/29/2019] [Indexed: 01/16/2023] Open
Abstract
Human papilloma virus (HPV) vaccine is a proven method for preventing HPV-related cancers and genital warts, especially preventing cervical cancer. It is aimed to systematically review and synthesize conclusions in detail from community-based studies published in Turkey between 2009 and 2019, which evaluate the knowledge, awareness, attitude, and behaviors of individuals towards HPV and HPV vaccination. This systematic review is conducted based on the PRISMA reporting method and includes community-based, descriptive cross-sectional and cross-sectional studies published between 2009 and 2019. In this systematic review, 5132 studies from six databases were scanned in total. It was determined that there were 23 studies that met the eligibility criteria for this systematic review. In the reviewed studies, it was determined that the rate of “Hearing of HPV before” was 3.8% at the lowest and 57.0% at the highest, and the rate of “Hearing of HPV vaccine before” was 2.2% at the lowest and 74.7% at the highest. In the reviewed studies, it was reported that although parents’ willingness to have their daughters vaccinated with HPV vaccine varied between 14.4% and 68.0%, their willingness to have their sons vaccinated with HPV vaccine varied between 11.0% and 62.0%. In addition, it was reported that the lowest rate of vaccination with HPV vaccine among participants was 0.3% at the lowest and 6.0% at the highest. Consequently, it is considered that conducting common, systematic, and continuous health education programs aimed at both sexes and including both parents, which will increase the knowledge and awareness on HPV and its vaccine, would provide positive attitudes, and will be effective in protecting against HPV-related cancers.
Collapse
Affiliation(s)
- Serpil Özdemir
- Department of Public Health Nursing, University of Health Sciences Turkey, Gülhane Faculty of Nursing, Ankara, Turkey
| | - Rabia Akkaya
- Department of Public Health Nursing, University of Health Sciences Turkey, Gülhane Faculty of Nursing, Ankara, Turkey
| | - Kazım Emre Karaşahin
- Department of Obstetrics and Gynecology, University of Health Sciences Turkey, Gülhane Training and Research Hospital, Ankara, Turkey
| |
Collapse
|
12
|
Nelson B. Cervical and anal cancer prevention in jails and prisons: "A missed opportunity": Although cancers linked to the human papillomavirus are preventable through vaccination and screening, these protective measures largely have been overlooked in correctional health care systems. Cancer Cytopathol 2020; 128:227-228. [PMID: 32251554 DOI: 10.1002/cncy.22268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
13
|
Emerson A, Allison M, Kelly PJ, Ramaswamy M. Barriers and facilitators of implementing a collaborative HPV vaccine program in an incarcerated population: A case study. Vaccine 2020; 38:2566-2571. [PMID: 32046888 DOI: 10.1016/j.vaccine.2020.01.086] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2019] [Revised: 01/27/2020] [Accepted: 01/28/2020] [Indexed: 01/29/2023]
Abstract
BACKGROUND Men and women in county jails make up a population that is difficult to reach with traditional preventive health interventions. Collaborations between local health departments and county jails represent an opportunity to enhance public health by reaching a vulnerable population with services like vaccinations. The objective of this study was to coordinate planning and implementation of a collaborative program between a local health department (HD) and a county jail to offer human papillomavirus (HPV) vaccinations to adolescents (ages 10-17) and young adults (ages 18-26) in the jail and to identify facilitators and barriers to inform future program development. METHODS A county-municipal jail and a local HD in Kansas participated. A case study method was employed based on data collected from a focus group, telephone interviews, and site observations, September 2016 to December 2017. Data were coded using codes roughly drawn from the consolidated framework for implementation research (CFIR). Codes were then consolidated into themes related to barriers and facilitators. RESULTS No adults were vaccinated; two juveniles were vaccinated. Barriers to a collaborative program to offer HPV vaccine to young adults arose in two areas: constrained resources and divergent organizational cultures and priorities. Barriers to offering HPV vaccinations to juveniles in the jail included parental consent and the unpredictable, often brief duration of juvenile detentions. A shared commitment to offering HPV vaccination services by leaders and staff in the two agencies was a key facilitator. CONCLUSION Finding ways to leverage leadership and staff buy-in and address specific barriers of constrained resources and divergent culture and priorities merits close attention, since partnerships between jails and local HD have potential to increase HPV vaccination rates in an overlooked population and advance public health.
Collapse
Affiliation(s)
- Amanda Emerson
- University of Missouri-Kansas City, School of Nursing and Health Studies, 2464 Charlotte St, Kansas City, MO 64108, USA.
| | - Molly Allison
- University of Kansas School of Medicine, 3901 Rainbow Blvd, Kansas City, KS 66160, USA.
| | - Patricia J Kelly
- University of Missouri-Kansas City, School of Nursing and Health Studies, 2464 Charlotte St, Kansas City, MO 64108, USA.
| | - Megha Ramaswamy
- University of Kansas School of Medicine, 3901 Rainbow Blvd, Kansas City, KS 66160, USA.
| |
Collapse
|
14
|
Brousseau EC, Ahn S, Matteson KA. Cervical Cancer Screening Access, Outcomes, and Prevalence of Dysplasia in Correctional Facilities: A Systematic Review. J Womens Health (Larchmt) 2019; 28:1661-1669. [PMID: 30939063 DOI: 10.1089/jwh.2018.7440] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
Abstract
Background: Incarcerated women often access health care primarily through contact with correctional systems. Cervical cancer screening within the correctional system can address the preventable outcome of cervical dysplasia and cancer in this high-risk population. Materials and Methods: A search of PubMed, EMBASE, CINAHL, and ClinicalTrials.gov was conducted for articles published between January, 1966 and December, 2018. All studies on a population of jailed or incarcerated females and at least one of the following outcomes: cervical cancer or dysplasia, pap smear screening, knowledge about screening, treatment of cervical dysplasia, and compliance with follow-up were analyzed. Results: Forty-two studies met inclusion criteria. All 21 studies with prevalence outcomes described a higher prevalence of cervical dysplasia and cancer in the women involved with corrections, compared to a variety of different sources that served as community control groups. The data on screening outcomes were inconsistent. Follow-up compliance for abnormal results was poor, with a study finding that only 21% of women were rescreened within 6 months of the recommended time period. Knowledge about cervical cancer and screening was evaluated in eight studies and was poor across all studies. Conclusion: Women involved in correctional systems have a higher prevalence of cervical dysplasia and cancer than women in the general population. Acceptance of screening varies, and no published interventions have been shown to improve screening within the prison system. Treatment and compliance with follow-up recommendations are extremely poor and should be a focus of future research.
Collapse
Affiliation(s)
- Erin Christine Brousseau
- Department of Obstetrics and Gynecology, Women and Infants Hospital and the Warren Alpert Medical School of Brown University, Providence, Rhode Island
| | - Susie Ahn
- Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina
| | - Kristen A Matteson
- Department of Obstetrics and Gynecology, Women and Infants Hospital and the Warren Alpert Medical School of Brown University, Providence, Rhode Island
| |
Collapse
|
15
|
Satterwhite CL, French V, Allison M, Honderick T, Ramaswamy M. Access to contraception in local health departments, four Midwest states, 2017-2018. Contraception 2019; 99:363-367. [PMID: 30871935 DOI: 10.1016/j.contraception.2019.02.009] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2018] [Revised: 02/19/2019] [Accepted: 02/20/2019] [Indexed: 10/27/2022]
Abstract
OBJECTIVE Describe contraception availability at local health departments (LHDs) serving largely rural populations. STUDY DESIGN We invited administrators at LHDs located in four Midwest states to participate in an online survey conducted from September 2017-April 2018. We collected data on clinic staffing, patient population, receipt of Title X funds, and services provided to assess the proportion of LHDs providing any prescription method of contraception; secondary outcomes included healthcare staff training level and other reproductive health services provided. RESULTS Of 344 LHDs invited, 237 administrators completed the survey (68.9%). Three-quarters served rural populations. One-third (34.6%) provided short-acting hormonal contraception; however, availability varied by state (Kansas: 58.0%, 40/69; Missouri: 37.5%, 33/88; Nebraska: 16.7%, 3/18; Iowa: 9.7%, 6/62; p<.01). Only 8.4% of LHDs provided IUDs; 7.6% provided implants, and 5.9% provided both methods. LHDs in Nebraska and Kansas provided any long-acting method more frequently (Kansas: 17.4%, Nebraska: 16.7%, Iowa: 8.1%, Missouri: 4.6%; p=.04). LHDs receiving Title X funds (27.0%) were much more likely to provide any prescription contraception (85.1% vs. 14.2%, p<.01). Most LHDs relied on registered nurses (RNs) to provide medical care; 81.0% reported that RNs provided care≥20 days per month. Pregnancy testing was widely available in Missouri and Kansas (>87%) and less commonly available in Iowa and Nebraska (<18%) (p<.01). CONCLUSION LHDs in these states are currently ill-equipped to offer comprehensive contraceptive services. Women seeking care at LHDs have limited, if any, contraceptive options. IMPLICATIONS Local health departments in the Midwest, serving a largely rural population, rarely offer prescription contraception, especially long-acting reversible methods. Women residing in settings without broad access to publicly-funded healthcare providers may have limited access to comprehensive contraceptive services. Efforts to ensure rural access are needed.
Collapse
Affiliation(s)
- Catherine Lindsey Satterwhite
- University of Kansas School of Medicine, Department of Preventive Medicine and Public Health, 3901 Rainbow Blvd, MS: 1008, Kansas City, KS 66160; University of Kansas School of Medicine, Department of Obstetrics and Gynecology, 3901 Rainbow Blvd, MS: 2028, Kansas City, KS 66160.
| | - Valerie French
- University of Kansas School of Medicine, Department of Obstetrics and Gynecology, 3901 Rainbow Blvd, MS: 2028, Kansas City, KS 66160.
| | - Molly Allison
- University of Kansas School of Medicine, Department of Preventive Medicine and Public Health, 3901 Rainbow Blvd, MS: 1008, Kansas City, KS 66160.
| | - Tanya Honderick
- University of Kansas School of Medicine, Department of Preventive Medicine and Public Health, 3901 Rainbow Blvd, MS: 1008, Kansas City, KS 66160.
| | - Megha Ramaswamy
- University of Kansas School of Medicine, Department of Preventive Medicine and Public Health, 3901 Rainbow Blvd, MS: 1008, Kansas City, KS 66160.
| |
Collapse
|